This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
All Good Things: PPI, Jobless Claims, Q3 Earnings
by Mark Vickery
While jobless claims are hitting fresh post-Covid lows, PPI curbs a bit and Q3 earnings beats abound.
Initial Jobless Claims Hit Fresh Post-Covid Low
by Zacks Equity Research
Initial Jobless Claims Hit Fresh Post-Covid Low
UnitedHealth (UNH) Beats on Q3 Earnings & Revenues, Ups View
by Zacks Equity Research
UnitedHealth (UNH) Q3 results reflect revenue growth at both the business units and increased membership.
Edwards Lifesciences (EW) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Improvement in Critical Care and Surgical Structural Heart businesses is expected to have contributed to Edwards Lifesciences' (EW) third-quarter results.
UnitedHealth Group (UNH) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.49% and 1.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Abbott Laboratories, UnitedHealth, Quest, and West Pharmaceutical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, UnitedHealth, Quest, and West Pharmaceutical
Growing COVID-19 Testing Demand to Boost Abbott's (ABT) Q3 Earnings
by Zacks Equity Research
Through July to September, Abbott's (ABT) Diagnostic business is likely to have benefited from the significant surge in the new COVID-19 case counts.
Thermo Fisher (TMO) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Thermo Fisher's (TMO) recent launches within Chromatography and Mass Spectrometry like Thermo Scientific Orbitrap IQ-X Tribrid Mass Spectrometer should have contributed to its Q3 top line.
5 Top Charts to Start Earnings Season
by Tracey Ryniec
Earnings season officially starts this week but it¿¿¿s not just the banks that are stocks to watch.
The Zacks Analyst Blog Highlights: JPMorgan, Bank of America, UnitedHealth, U.S. Bancorp and PNC Financial Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, Bank of America, UnitedHealth, U.S. Bancorp and PNC Financial Services
Infosys (INFY) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Though the ongoing digital transformations and large deal wins are likely to have aided Infosys' (INFY) Q2 top-line performance, elevated expenses might have hurt its profitability.
Humana's (HUM) 2022 Expansion Plan to Boost MA Customer Base
by Zacks Equity Research
Humana (HUM) declares enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties to offer improved health outcomes.
What's in Store for UnitedHealth's (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to report a rise in earnings and revenues.
The Calm Before The Storm
by Daniel Laboe
Institutional money managers are enjoying one last warm holiday on their yacht's before hanging up the Tommy Bahama and preparing for this market catalyzing earnings season
What Lies Ahead for Dow ETFs in Q3 Earnings?
by Sweta Killa
With some of the blue-chip companies expected to report an earnings surprise, investors should closely monitor the movement of the Dow ETF.
5 Large-Cap Stocks Likely to Gain From Q3 Earnings This Week
by Nalak Das
Five corporate bigwigs are slated to release third-quarter earnings results this week. These are: JPM, BAC, PNC, USB and UNH.
Cigna (CI) Divests Unit to Chubb to Streamline Business
by Zacks Equity Research
Cigna (CI) sells its businesses to Chubb to focus on core growth areas.
UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.
Teladoc (TDOC) Broadens Accessibility of Primary Care Model
by Zacks Equity Research
Teladoc Health (TDOC) intends to offer enhanced primary care to its members through Primary360, whose reach has now extended to commercial health plans and employers.
Is UnitedHealth Group (UNH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Is a Surprise Coming for UnitedHealth (UNH) This Earnings Season?
by Zacks Equity Research
UnitedHealth (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
UnitedHealth Group (UNH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Hold Onto Anthem (ANTM) in Your Portfolio?
by Zacks Equity Research
A solid positioning in an ever-growing industry along with strong fundamentals make Anthem (ANTM) a good fit for investment gains.
Can UnitedHealth (UNH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Centene (CNC) Expands Medicare Advantage Offerings in 36 States
by Zacks Equity Research
Centene (CNC) boosts its Medicare Advantage offerings in 1,575 counties across 36 states in a bid to provide affordable and quality healthcare.